Yuki Yamasaki

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

Serena Deiana, Akihito Watanabe, Yuki Yamasaki et al. · Psychopharmacology · 2011 · 391 citations

Cannabis Use, Obsessive–compulsive Behaviour, Psychiatry +11

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

Nicholas A. Jones, Sarah Glyn, Satoshi Akiyama et al. · Seizure · 2012 · 241 citations · Full text

Cannabis Use, Neurophysiology, Medicine +12

Cannabidivarin is anticonvulsant in mouse and rat

A.G. Hill, M. Mercier, TDM Hill et al. · British Journal of Pharmacology · 2012 · 171 citations · Full text

Protective effect against Parkinson's disease-related insults through the activation of XBP1

Megumi Sado, Yuki Yamasaki, Tomoyuki Iwanaga et al. · Brain Research · 2008 · 146 citations

Medicine, Parkinson Disease, Pharmacology +9

Self‐Degradable Lipid‐Like Materials Based on “Hydrolysis accelerated by the intra‐Particle Enrichment of Reactant (HyPER)” for Messenger RNA Delivery

Hiroki Tanaka, Tatsunari Takahashi, Manami Konishi et al. · Advanced Functional Materials · 2020 · 111 citations · Full text

Messenger Rna Delivery, Nanomedicine, Cell-based Drug Delivery +15